12
Participants
Start Date
March 3, 2020
Primary Completion Date
January 21, 2028
Study Completion Date
June 1, 2028
Microdevice
"Placement of 1-3 microdevices (depending on the size of the tumor) before tumor resection is started.~The microdevices will dwell in the tumor tissue for a time window of 2-4 hours to allow time for tissue effects of the drugs (Temozolomide, Lomustine, Irinotecan, Carboplatin, Lapatinib, Osimertinib, Abenaciclib, and Everolimus) released by the microdevice reservoirs. The drugs used in this study will only include drugs already used systemically for the treatment of gliomas."
RECRUITING
Brigham and Women's Hospital, Boston
Oliver Jonas
OTHER